{'fraction_non_alphanumeric': 0.07045895281189399, 'fraction_numerical': 0.06658047834518423, 'mean_word_length': 5.1673306772908365, 'pattern_counts': {'":': 0, '<': 2, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Clinical characteristics of Severe Acute Respiratory Syndrome by COVID-19 in Indigenous of Brazil

The indigenous people of Brazil present several cases and deaths, affecting 158 peoples, with high vulnerability and limited access to health services. The objective is to investigate the clinical characteristics of severe acute respiratory syndrome by COVID-19 in indigenous peoples of Brazil. The epidemiological study, descriptive, from the data of the platform opendataSUS referring to the SIVEP-GRIPE in the period 01/01/2020 until 31/08/2020. Profile variables, signs and symptoms, and risk/comorbidities factors. The data were analyzed by Bioestat 5.3. 1,207 cases and 470 deaths. Profile: male gender (59.48%) mean age 53. Signs and symptoms: fever (74.23%), cough (77.71%), sore throat (35.62%), dyspnea (69.34%), respiratory discomfort (62.80%), O2 saturation <95% (56.42%); and associated with mortality: dyspnea (80.0%) and O2 saturation <95% (69.36%). Risk factors and comorbidities (45.89%) were associated with deaths (54.04%). Comorbidities: Chronic Cardiovascular Disease (18.97%) and Diabetes Mellitus (18.97%), and associated with deaths: Chronic Cardiovascular Disease (24.46%). There was significance in the survivors vaccinated for influenza (26.18%). The public and health policies of Brazil should be directed to control the dissemination of COVID-19 in this population, that COVID-19 evolves in the same intensity, however, the indigenous have vulnerabilities that can enhance the impact of the pandemic in this population.